Delorazepam
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | DrugCentral | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | nordiclazepam | — | — | |
| Safety | ||||
| Dose · Oral | ||||
| Light | 0.25–0.5 mg | — | — | |
| Common | 0.5–1.5 mg | — | — | |
| Strong | 1.5–2 mg | — | — | |
| Heavy | 2 mg+ | — | — | |
| Duration | ||||
| Onset | 30–60 minutes | — | — | |
| Total | 12–16 hours | — | — | |
| After-effects | 72 hours | — | — | |
| Pharmacology | ||||
| Receptor activity | — | — | GABRA1GABRP | |
| Half-life | — | Very long elimination half life of 80-115 hours, varying with age. Elimination is slower as age increases. [1] Liver disease also impacts elimination half life, with impairment resulting in half lives up to 395 hours. | — | |
| Protein binding | — | >90% protein bound. | — | |
TripSit summary
Also known as chlordesmethyldiazepam, this uncommon benzodiazepine compound is primarily used for treatment of anxiety and alcohol withdrawal, due to its long half-life (60-140 hours). It is also the active metabolite of diclazepam and cloxazolam.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.